According to Silence Therapeutics's latest financial reports the company has a price-to-book ratio of 10.9664.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 2.65 | -91.43% |
2023-12-31 | 30.9 | 50.85% |
2022-12-31 | 20.5 | -63.25% |
2021-12-31 | 55.8 | 18.54% |
2020-12-31 | 47.1 | 258.74% |
2019-12-31 | 13.1 | 1137.54% |
2018-12-31 | 1.06 | |
2017-12-31 | N/A | |
2016-12-31 | N/A | -100% |
2015-12-31 | 1.93 | -50.36% |
2014-12-31 | 3.88 | |
2013-12-31 | N/A | |
2012-12-31 | N/A | |
2011-12-31 | N/A | |
2010-12-31 | N/A | |
2009-12-31 | N/A | |
2008-12-31 | N/A | |
2007-12-31 | N/A | |
2006-12-31 | N/A | |
2005-12-31 | N/A | |
2004-12-31 | N/A | |
2003-12-31 | N/A |